Steven K. Engle

1.0k total citations
14 papers, 797 citations indexed

About

Steven K. Engle is a scholar working on Cardiology and Cardiovascular Medicine, Oncology and Surgery. According to data from OpenAlex, Steven K. Engle has authored 14 papers receiving a total of 797 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Cardiology and Cardiovascular Medicine, 3 papers in Oncology and 2 papers in Surgery. Recurrent topics in Steven K. Engle's work include Heart Failure Treatment and Management (6 papers), Cardiac electrophysiology and arrhythmias (6 papers) and Cardiovascular Function and Risk Factors (2 papers). Steven K. Engle is often cited by papers focused on Heart Failure Treatment and Management (6 papers), Cardiac electrophysiology and arrhythmias (6 papers) and Cardiovascular Function and Risk Factors (2 papers). Steven K. Engle collaborates with scholars based in United States, Belgium and United Kingdom. Steven K. Engle's co-authors include Thomas H. Everett, Sander Verheule, Jeffrey E. Olgin, Hidehiro Nakajima, Michael Rubart‐von der Lohe, Toshiaki Sato, Loren J. Field, Hisako O. Nakajima, Jinqi Xia and J. K. Saha and has published in prestigious journals such as Circulation Research, Journal of Pharmacology and Experimental Therapeutics and Toxicological Sciences.

In The Last Decade

Steven K. Engle

13 papers receiving 776 citations

Peers

Countries citing papers authored by Steven K. Engle

Since Specialization

Citations

This map shows the geographic impact of Steven K. Engle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steven K. Engle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steven K. Engle more than expected).

Fields of papers citing papers by Steven K. Engle

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steven K. Engle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steven K. Engle. The network helps show where Steven K. Engle may publish in the future.

Co-authorship network of co-authors of Steven K. Engle

This figure shows the co-authorship network connecting the top 25 collaborators of Steven K. Engle. A scholar is included among the top collaborators of Steven K. Engle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steven K. Engle. Steven K. Engle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

#	Work	Indexed citations
1	Gemogenovatucel-T (Vigil): bi-shRNA plasmid-based targeted immunotherapy 2024 ·Future Oncology ·John Nemunaitis, Laura Stanbery, (unknown), Gladice Wallraven, (unknown), Staci Horvath, Ernest Bognar, (unknown), Steven K. Engle, Scott Brun, (unknown), Rodney P. Rocconi, Bradley J. Monk, Robert L. Coleman	1
2	Comparison of ANP and BNP Granular Density in Atria of Rats After Physiological and Pathological Hypertrophy 2022 ·Toxicologic Pathology ·Kevin Agostinucci, Thomas G. Manfredi, (unknown), Frederick J. Vetter, Steven K. Engle	4
3	Evaluating Associations Between Nonclinical Cardiovascular Functional Endpoints and Repeat-dose Cardiovascular Toxicity in the Beagle Dog: A Cross-company Initiative 2020 ·Toxicological Sciences ·Philip H. Milliken, Mike Aylott, (unknown), Steven K. Engle, Lorna Ewart, (unknown), Magali Guffroy, Adam Hargreaves, Kathleen M. Heinz-Taheny, Sarah Kirk, Derek J. Leishman, (unknown), Nick McMahon, Jean‐Pierre Valentin, David E. Watson, Rob Wallis, Peter Clements	4
4	Serum Natriuretic Peptides as Differential Biomarkers Allowing for the Distinction between Physiologic and Pathologic Left Ventricular Hypertrophy 2016 ·Toxicologic Pathology ·Michael E. Dunn, Thomas G. Manfredi, Kevin Agostinucci, Steven K. Engle, (unknown), Nicholas M. P. King, (unknown), Kathryn E. Gropp, (unknown), Frederick J. Vetter, Vijay R. More, (unknown), (unknown), Heidi M. Colton	8
5	Evaluation of Cardiac Toxicity Biomarkers in Rats from Different Laboratories 2016 ·Toxicologic Pathology ·Kyuri Kim, (unknown), David G. Fairchild, Steven K. Engle, William J. Reagan, (unknown), Jon C. Mirsalis	18
6	Cross-laboratory analytical validation of the cardiac biomarker NT-proANP in rat 2015 ·Journal of Pharmacological and Toxicological Methods ·Petra Vinken, William J. Reagan, (unknown), Wayne R. Buck, Jie Lai‐Zhang, (unknown), (unknown), Ray Liu, Nicholas M. P. King, Steven K. Engle, Heidi M. Colton	8
7	Natriuretic Peptides as Cardiovascular Safety Biomarkers in Rats: Comparison With Blood Pressure, Heart Rate, and Heart Weight 2015 ·Toxicological Sciences ·Steven K. Engle, David E. Watson	6
8	Biomarkers of Exocrine Pancreatic Injury in 2 Rat Acute Pancreatitis Models 2013 ·Toxicologic Pathology ·Amy Usborne, Aaron T. Smith, Steven K. Engle, David E. Watson, John M. Sullivan, Jennie Walgren	25
9	Detection of Left Ventricular Hypertrophy in Rats Administered a Peroxisome Proliferator–Activated Receptor α/γ Dual Agonist Using Natriuretic Peptides and Imaging 2009 ·Toxicological Sciences ·Steven K. Engle, Philip F. Solter, Kelly M. Credille, (unknown), (unknown), Michael J. Berna, A. Eric Schultze, Emily C. Rothstein, Michael D. Cockman, (unknown), Hong Liu, Yuefeng Lu, Alan Y. Chiang, David E. Watson	23
10	Qualification of Cardiac Troponin I Concentration in Mouse Serum Using Isoproterenol and Implementation in Pharmacology Studies to Accelerate Drug Development 2009 ·Toxicologic Pathology ·Steven K. Engle, William H. Jordan, (unknown), Alan Y. Chiang, Myrtle A. Davis, (unknown), Daniel G. Rudmann, Kathleen M. Heinz-Taheny, Armando R. Irizarry, Yumi Yamamoto, David Mendel, A. Eric Schultze, Paul D. Cornwell, David E. Watson	35
11	A Model of Controlled Acute Hyperglycemia in Rats: Effects of Insulin and Glucagon-Like Peptide-1 Analog 2006 ·Journal of Pharmacology and Experimental Therapeutics ·J. K. Saha, Jinqi Xia, Steven K. Engle, Yun-Fei Chen, Wolfgang Glaesner, Joseph A. Jakubowski	12
12	Acute Hyperglycemia Induced by Ketamine/Xylazine Anesthesia in Rats: Mechanisms and Implications for Preclinical Models 2005 ·Experimental Biology and Medicine ·J. K. Saha, Jinqi Xia, (unknown), Steven K. Engle, Joseph A. Jakubowski	207
13	Increased Vulnerability to Atrial Fibrillation in Transgenic Mice With Selective Atrial Fibrosis Caused by Overexpression of TGF-β1 2004 ·Circulation Research ·Sander Verheule, Toshiaki Sato, Thomas H. Everett, Steven K. Engle, (unknown), Michael Rubart‐von der Lohe, Hisako O. Nakajima, Hidehiro Nakajima, Loren J. Field, Jeffrey E. Olgin	435
14	Interleukin-5 inhibition of biliary cell chloride currents and bile flow 2001 ·American Journal of Physiology-Gastrointestinal and Liver Physiology ·James M. McGill, (unknown), Oscar W. Cummings, Gianfranco Alpini, Gene LeSage, Karen E. Pollok, Barbara A. Miller, Steven K. Engle, (unknown)	11

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact